Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
Clinical trial NCT00983437 · TERMINATED
Trial details
- NCT number
- NCT00983437
- Sponsor
- Cephalon, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-31
- Primary completion
- 2011-01-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.